by Jordana Choucair | Nov 30, 2022 | Opioid/Substance Use Disorders
New data published Wednesday by the National Center for Health Statistics show that deaths from drug and alcohol use are rising among America’s seniors. According to the data, drug overdose deaths more than tripled among people aged 65 and older during the past two...
by Jordana Choucair | Nov 30, 2022 | M&A
Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of...
by Jordana Choucair | Nov 30, 2022 | Mental Health
New York City Mayor Eric Adams unveiled a new plan to remove people with severe, untreated mental illness from city streets and subways. Under the plan, New York City agencies – such as the New York Police Department and New York City Fire Department – and emergency...
by Jordana Choucair | Nov 30, 2022 | Providers
The Centers for Medicare & Medicaid Services (CMS) published a memo reminding hospitals of their responsibility to protect patients and health care workers from physical violence in the workplace. The memo said hospitals should be able to demonstrate their...
by Jordana Choucair | Nov 30, 2022 | Public Health/Prevention
The Centers for Disease Control and Prevention (CDC) announced it is awarding $3.2 billion to help strengthen public health workforce and infrastructure across the U.S. after the COVID-19 pandemic put severe stress on them. The funding includes $3 billion from the...
by Jordana Choucair | Nov 29, 2022 | Life Sciences
Research published in JAMA Internal Medicine revealed that Food and Drug Administration (FDA) approvals of “skinny labels” on biosimilars saved Medicare over $1 billion over five years. According to the research, the FDA approved 33 biosimilars based on 11...
Recent Comments